Formulation and Evaluation on Synergetic Anti-Hepatoma Effect of a Chemically Stable and Release-Controlled Nanoself-Assembly with Natural Monomers
DOI: https://doi.org/10.2147/IJN.S408416
IF: 7.033
2023-06-23
International Journal of Nanomedicine
Abstract:Lanlan Zong, 1, &ast Yanling Wang, 1, &ast Shiyu Song, 1 Huiqi Zhang, 1 Shengcai Mu, 1 Wenshang Liu, 1 Yu Feng, 1 Shumin Wang, 1 Ziwei Tu, 1 Qi Yuan, 1 Luhui Li, 2 Xiaohui Pu 1 1 School of Pharmacy and Henan Province Engineering Research Center of High Value Utilization to Natural Medical Resource in Yellow River Basin, Henan University, Kaifeng, Henan, 475004, People's Republic of China; 2 Medical school, Henan Technical Institute, Kaifeng, Henan, 475004, People's Republic of China &astThese authors contributed equally to this work Correspondence: Qi Yuan; Xiaohui Pu, Tel/Fax +86-371-23880680, Email ; Introduction: Hepatoma is the leading cause of death among liver diseases worldwide. Modern pharmacological studies suggest that some natural monomeric compounds have a significant effect on inhibiting tumor growth. However, poor stability and solubility, and side effects are the main factors limiting the clinical application of natural monomeric compounds. Methods: In this paper, drug-co-loaded nanoself-assemblies were selected as a delivery system to improve the chemical stability and solubility of Tanshinone II A and Glycyrrhetinic acid, and to produce a synergetic anti-hepatoma effect. Results: The study suggested that the drug co-loaded nanoself-assemblies showed high drug loading capacity, good physical and chemical stability, and controlled release. In vitro cell experiments verified that the drug-co-loaded nanoself-assemblies could increase the cellular uptake and cell inhibitory activity. In vivo studies verified that the drug co-loaded nanoself-assemblies could prolong the MRT 0-∞ , increase accumulation in tumor and liver tissues, and show strong synergistic anti-tumor effect and good bio-safety in H22 tumor-bearing mice. Conclusion: This work indicates that natural monomeric compounds co-loaded nanoself-assemblies would be a potential strategy for the treatment of hepatoma. Graphical Keywords: nanoself-assemblies, drug combination, glycyrrhetinic acid, tanshinone IIA, liver cancer Graphical It was reported that the total number of chronic liver disease patients in China could be over 447 million people in 2020. 1 As a complication of hepatitis, hepatoma is the main cause of death. The clinical studies from Translation Chinese Medicine (TCM) have shown that the blood stasis syndrome was present throughout the development of liver cancer (Hepatoma), and promoting blood circulation for removing blood stasis medicine can effectively inhibit the development of liver cancer, especially the strengthening the middle warmer and benefiting vital energy drugs can effectively improve the deficiency of promoting blood circulation for removing blood stasis drugs alone, inhibit tumor metastasis and reduce immune inflammatory response. 2 For example, Salvia miltiorrhiza-Licorice (named Danshen-Gancao in Chinese) is one of the famous couplet herbs with functions of promoting blood circulation, removing blood stasis, strengthening the middle warmer and benefiting vital energy for the treatment of liver cancer. Tanshinone II A (TAN) is a major lipophilic non-quinone compound extracted from the root of Salvia miltiorrhiza, 3 and Glycyrrhetinic acid (GA) is a pentacyclic triterpenoid glycoside with poor solubility derived from the root of licorice. Modern pharmacological studies suggest that they have a very wide range of pharmacological activities, such as TAN has anti-oxidation, anti-inflammatory, anti-thrombosis, lowering blood pressure, regulating vascular endothelial dysfunction, anti-liver fibrosis and anti-tumor activity, 4 GA has antioxidant, anti-inflammatory, liver protection, antiviral activities, and so on. 5 However, these two natural components have some defects, such as low oral bioavailability 6,7 and side effects which TAN has an allergic reaction, bradycardia, tachycardia, drug-induced hepatitis, diarrhoea, muscle tremor, uremia, severe growth inhibition and developmental malformations of embryos, 3 and GA has water-sodium retention, oedema, hypertension and cardiac dysfunction after long-term and extensive application. 8 TAN also has photothermal instability and strong liver first-pass effect. 9 Their disadvantages greatly hinder the use of both in clinical treatment. Luckily, TAN and GA have broad and similar effects on anti-cancer and mutual easing effects in terms of side effects. What is more, TAN and GA have been proven to have good inhibitory effects on liver cancer at the genetic, cellular a -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology